BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15653701)

  • 1. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital.
    Spurrell EL; Fisher C; Thomas JM; Judson IR
    Ann Oncol; 2005 Mar; 16(3):437-44. PubMed ID: 15653701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment.
    Spillane AJ; A'Hern R; Judson IR; Fisher C; Thomas JM
    J Clin Oncol; 2000 Nov; 18(22):3794-803. PubMed ID: 11078492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
    Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience.
    Ates O; Aksoy S; Yeter H; Sunar V; Kertmen N; Dizdar O; Turker A; Kars A
    Indian J Cancer; 2017; 54(1):321-325. PubMed ID: 29199714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen.
    Salah S; Yaser S; Salem A; Al Mousa A; Abu Sheikha A; Sultan I
    Med Oncol; 2013; 30(3):639. PubMed ID: 23780657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of renal synovial sarcoma treated with adjuvant ifosfamide and doxorubicin.
    Ozkan EE; Mertsoylu H; Ozardali HI
    Intern Med; 2011; 50(15):1575-80. PubMed ID: 21804284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
    Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
    Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination effect of pirarubicin, ifosfamide, and vincristine sulfate in the treatment of advanced synovial sarcoma--report of a case].
    Shinozaki T; Matsushita M; Kusawake H; Watanabe H; Arita S; Chigira M; Udagawa E
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1389-91. PubMed ID: 7668875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Treatment for Adults with Synovial Sarcoma.
    Desar IME; Fleuren EDG; van der Graaf WTA
    Curr Treat Options Oncol; 2018 Mar; 19(2):13. PubMed ID: 29516254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of renal synovial sarcoma: complete remission was induced by chemotherapy with doxorubicin and ifosfamide.
    Park SJ; Kim HK; Kim CK; Park SK; Go ES; Kim ME; Hong DS
    Korean J Intern Med; 2004 Mar; 19(1):62-5. PubMed ID: 15053047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of prognostic factors for synovial sarcoma].
    Du ZY; Guo W; Yang RL; Yan TQ; Li DS
    Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):991-4. PubMed ID: 22333419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma.
    Wu Y; Bi W; Han G; Jia J; Xu M
    World J Surg Oncol; 2017 May; 15(1):101. PubMed ID: 28494784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
    Kojima Y; Shimoi T; Seo T; Yazaki S; Okuya T; Ohtake Y; Okuma HS; Shimomura A; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Tamura K; Yoshida A; Iwata S; Kobayashi E; Kawai A; Fujiwara Y; Yonemori K
    Oncology; 2022; 100(7):370-375. PubMed ID: 35405680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of palliative chemotherapy in advanced epithelioid sarcoma.
    Jones RL; Constantinidou A; Olmos D; Thway K; Fisher C; Al-Muderis O; Scurr M; Judson IR
    Am J Clin Oncol; 2012 Aug; 35(4):351-7. PubMed ID: 21422990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal synovial sarcoma.
    Domşa I; Crişan D; Olinici CD
    Rom J Morphol Embryol; 2006; 47(2):187-91. PubMed ID: 17106529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
    Young RJ; Litière S; Lia M; Hogendoorn PCW; Fisher C; Mechtersheimer G; Daugaard S; Sciot R; Collin F; Messiou C; Grünwald V; Gronchi A; van der Graaf W; Wardelmann E; Judson I
    Acta Oncol; 2017 Jul; 56(7):1013-1020. PubMed ID: 28431480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
    Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.